BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Department of Radiology, University Hospital Virgen de La Arrixaca, Murcia, Spain.
Eur Radiol. 2022 Mar;32(3):2030-2040. doi: 10.1007/s00330-021-08282-1. Epub 2021 Sep 26.
To assess the precision of MRI radiomics features in hepatocellular carcinoma (HCC) tumors and liver parenchyma.
The study population consisted of 55 patients, including 16 with untreated HCCs, who underwent two repeat contrast-enhanced abdominal MRI exams within 1 month to evaluate: (1) test-retest repeatability using the same MRI system (n = 28, 10 HCCs); (2) inter-platform reproducibility between different MRI systems (n = 27, 6 HCCs); (3) inter-observer reproducibility (n = 16, 16 HCCs). Shape and 1st- and 2nd-order radiomics features were quantified on pre-contrast T1-weighted imaging (WI), T1WI portal venous phase (pvp), T2WI, and ADC (apparent diffusion coefficient), on liver regions of interest (ROIs) and HCC volumes of interest (VOIs). Precision was assessed by calculating intraclass correlation coefficient (ICC), concordance correlation coefficient (CCC), and coefficient of variation (CV).
There was moderate to excellent test-retest repeatability of shape and 1st- and 2nd-order features for all sequences in HCCs (ICC: 0.53-0.99; CV: 3-29%), and moderate to good test-retest repeatability of 1st- and 2nd-order features for T1WI sequences, and 2nd-order features for T2WI in the liver (ICC: 0.53-0.73; CV: 12-19%). There was poor inter-platform reproducibility for all features and sequences, except for shape and 1st-order features on T1WI in HCCs (CCC: 0.58-0.99; CV: 3-15%). Good to excellent inter-observer reproducibility was found for all features and sequences in HCCs (CCC: 0.80-0.99; CV: 4-15%) and moderate to good for liver (CCC: 0.45-0.86; CV: 6-25%).
MRI radiomics features have acceptable repeatability in the liver and HCC when using the same MRI system and across readers but have low reproducibility across MR systems, except for shape and 1st-order features on T1WI. Data must be interpreted with caution when performing multiplatform radiomics studies.
• MRI radiomics features have acceptable repeatability when using the same MRI system but less reproducible when using different MRI platforms. • MRI radiomics features extracted from T1 weighted-imaging show greater stability across exams than T2 weighted-imaging and ADC. • Inter-observer reproducibility of MRI radiomics features was found to be good in HCC tumors and acceptable in liver parenchyma.
评估 MRI 放射组学特征在肝细胞癌 (HCC) 肿瘤和肝脏实质中的精确性。
研究人群包括 55 名患者,其中 16 名未经治疗的 HCC 患者在 1 个月内接受了两次重复对比增强腹部 MRI 检查,以评估:(1) 使用相同 MRI 系统的测试-重测可重复性(n=28,10 个 HCC);(2) 不同 MRI 系统之间的平台间可重复性(n=27,6 个 HCC);(3) 观察者间可重复性(n=16,16 个 HCC)。在肝脏感兴趣区(ROI)和 HCC 体积感兴趣区(VOI)上,对 T1 加权成像(WI)、T1WI 门静脉期(pvp)、T2WI 和表观扩散系数(ADC)的预对比 T1WI、形状和一阶和二阶放射组学特征进行定量。通过计算组内相关系数(ICC)、一致性相关系数(CCC)和变异系数(CV)来评估精度。
在 HCC 中,所有序列的形状和一阶和二阶特征的测试-重测重复性均为中度至高度(ICC:0.53-0.99;CV:3-29%),T1WI 序列的一阶和二阶特征以及 T2WI 的测试-重测重复性为中度至良好肝脏中的序列(ICC:0.53-0.73;CV:12-19%)。除 HCC 中的 T1WI 上的形状和一阶特征外,所有特征和序列的平台间可重复性均较差(CCC:0.58-0.99;CV:3-15%)。在 HCC 中,所有特征和序列的观察者间可重复性均为良好至高度(CCC:0.80-0.99;CV:4-15%),肝脏为中度至良好(CCC:0.45-0.86;CV:6-25%)。
当使用相同的 MRI 系统和跨读者时,MRI 放射组学特征在肝脏和 HCC 中具有可接受的重复性,但在 MRI 系统之间的可重复性较低,T1WI 上的形状和一阶特征除外。在进行多平台放射组学研究时,必须谨慎解释数据。
使用相同的 MRI 系统时,MRI 放射组学特征具有可接受的重复性,但使用不同的 MRI 平台时,可重复性较低。
T1 加权成像提取的 MRI 放射组学特征比 T2 加权成像和 ADC 更稳定。
在 HCC 肿瘤中,MRI 放射组学特征的观察者间可重复性良好,在肝脏实质中可接受。